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Abstract – The present study used an RT-nested-PCR and an immunohistochemistry assay to detect
bovine respiratory syncytial virus in tissues from experimentally infected balb/c mice. As a first
step, Chicken Embryo Related (CER) cell monolayers infected with the BRSV-25-BR strain
isolated in Brazil were used for antigen production. Then, the infected lung and tracheal tissues of
female balb/c mice were collected on 3, 5, 7 and 10 days post-infection and submitted to both
techniques. Primers specific to F and G genes that amplify fragments of 481 bp and 371 bp,
respectively, were used. The BRSV detection was not successful in all of the animals tested. The
genomic fragment of the G gene from the organs of some infected mice on all analyzed post-
infection days was amplified. However, in the RT-nested-PCR corresponding to the F gene, it was
not possible to observe any amplified fragment. This was probably due to the higher sensitivity of
the developed technique to amplify the fragment corresponding to the G gene compared to the F
gene. Moreover, only three of the lungs collected five days post-infection were positive by
immunohistochemistry. To the author’s knowledge, this is the first study reporting bovine
respiratory syncytial virus detection in balb/c mice after experimental inoculation.
bovine respiratory syncytial virus / RT-nested-PCR / immunohistochemistry / mice /
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1. INTRODUCTION
The bovine respiratory syncytial virus
(BRSV) is an agent that belongs to the
Paramyxoviridae family, the Pneumovirus
genus, being one of the pathogens of higher
importance in respiratory diseases [23], and
responsible for significant economic losses
in commercial cattle production [7]. Spe-
cific antibodies for the BRSV are more
frequently detected in animals up to six
months of age [18]. In individuals of two
weeks to three months of age, the clinical
manifestation of the illness is inversely
related to the level of maternal specific
serum antibodies conferred to these animals
[16]. These maternal antibodies also inter-
fere with the serological diagnosis and with
the response to vaccination. 
Laboratory diagnosis of BRSV is gener-
ally based on criteria such as virus isolation,
BRSV antigen detection in the suspected
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tissues, serologic methods or histopatho-
logical examination. There are however,
frequent difficulties related to this due to its
limited growth in cell cultures or in the
majority of experimental animals, and to
the lability of the virus. Hence, the isolation
of the virus in cell cultures is a procedure
less indicated for the diagnosis of BRSV
infections, even in clinical samples contain-
ing high virus concentration. 
Currently, the diagnosis of BRSV infec-
tions is more commonly performed through
the detection of specific antibodies by
sero-diagnostic methods such as the serum
neutralization test, complement fixation
test, indirect immunofluorescence test and
ELISA [29, 30]. Although the serum neu-
tralization test is the standard gold test for
the detection of specific antibodies against
BRSV, difficulties arise regarding the time
needed to obtain the results, which takes an
average of 5 to 7 days [12]. Furthermore,
there are reports of asymptomatic infec-
tions by the Human Respiratory Syncytial
Virus (HRSV), which are serologically unde-
tectable [10]. In analogy to the HRSV, since
BRSV and HRSV are antigenetically related
of the up to 80% in proteins N, M, M2 and
F [31], is possible to speculate that part of
the infections by BRSV cannot be diagnosed
through the detection of specific serum
antibodies. This probably occurs due to the
simple fact that these animals do not
develop antibodies in levels high enough to
be detected by conventional techniques. In
addition, there is evidence indicating the
existence of latent infections, since the
virus has been isolated from asymptomatic
animals, as well as from animals infected
seven months before the appearance of the
symptoms [1].
There is an urgent need, therefore, for a
quick, sensitive and specific method for the
diagnosis of infections by the BRSV virus.
Several authors have been working on the
development of techniques to simplify and
to increase the sensitivity of BRSV infec-
tion diagnosis. The reverse transcription-
PCR assay has shown high speed, sensitiv-
ity and specificity in great parts of these
works [20–22, 27, 28], providing a valuable
tool for diagnostic and epidemiological
purposes.
Experimental animals represent a useful
alternative for experiments with viruses
and other microorganisms, mainly when it
is not possible to work with their natural
host. Collins et al. [10] have pointed out
that a wide range of animals, including
marmosets, nonhuman primates, ferrets,
mink, chinchillas, guinea pigs, cotton rats
and mice, could be experimentally infected
when RSV is inoculated directly into the
respiratory tract. Small experimental ani-
mals have been used as models of lower
respiratory tract infection with RSV [5, 8,
9, 15, 17, 19, 24, 25]. The present study
detected BRSV in experimentally infected
balb/c mice by RT-nested-PCR and immu-
nohistochemistry. 
2. MATERIALS AND METHODS 
2.1. Virus 
The Brazilian BRSV-25-BR strain, iso-
lated in the Laboratorio de Virologia
Animal do Institute de Biologia da Univer-
sidade Estadual de Campinas (UNICAMP)
[2], was used in the present study. This
strain was isolated from samples of
nasotracheal secretions collected from live
animals from the Southern and Southeast-
ern Brazilian States, inoculated succes-
sively in MDBK (Madin Darby Bovine
Kidney) and CER (Chicken Embryo
Related) cells. 
2.2. Cells 
The cell cultures used were from the
continuous cell line of CER. The cells were
cultivated in bottles of 75 cm2, with 1.5 ×
105 cells/mL (initial concentration) in min-
imal essential Eagle medium (MEME)
supplemented with 10% BRSV-free fetal
calf serum (FCS) and kept at 37 °C.
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2.3. Antigen production 
For the production of the viral antigen
used in the mice infection and submitted to
the extraction of the viral RNA for RT-
nested-PCR, cellular monolayers, were
inoculated with 104.3 DICC50/mL of the
BRSV-25-BR strain. The bottles were incu-
bated at 37 °C and the cells were observed
daily under an inverted light microscope
(Axiovert 100, Carl Zeiss, Oberkochen,
Germany) in order to detect a cytopathic
effect (CPE). Then, the infected cells were
submitted to RNA extraction or scraped and
the supernatant was clarified through cen-
trifugation, aliquoted and stored at –70 °C
until use in the mice infection. 
2.4. Animal infection 
During the experiment, all mice were
kept in the laboratory animal house of the
Departamento de Microbiologia e Immun-
ologia do Instituto de Biologia da UNI-
CAMP. The infected animals were installed
separately from negative control animals.
Four-week-old specific-pathogen-free
(SPF) female balb/c mice, purchased from
the Centro Multidisciplinar de Investigação
Biológica of UNICAMP (CEMIB-UNI-
CAMP), kept behind barriers, were used in
this study. The animals were distributed
into two groups, one containing 16 animals
and the other, a negative control, containing
8 animals. All animals of the first group
were intranasally inoculated with 100 µL of
the viral antigen with an infectious dose of
104.3 DICC50/mL, using a micropipette.
The negative control animals received an
amount of supernatant CER cells free of
virus. The animals were observed daily for
clinical signs. The samples of lung and tra-
cheal tissues of the infected (4 animals) and
control group (2 animals), collected 3, 5,
7 and 10 days post-infection (dpi), were
submitted to immunohistochemistry and
RT-nested-PCR assays. These inoculations
were performed in three repetitions, in dif-
ferent periods of time, resulting in a total of
48 virus-infected and 24 mock-infected
animals. 
2.5. Histopathology
Tissue samples were fixed in 4% para-
formaldehyde (Sigma-Aldrish Co., Mis-
souri, USA), embedded in paraffin wax, cut
in 4 µm thick sections, and mounted on
microscope slides. For a routine histologi-
cal examination, the sections were stained
with haematoxylin and eosin (HE). The
same protocol was used for section prepa-
ration for the immunohistochemistry assay.
2.6. Immunohistochemistry (IHC)
Immunohistochemistry was carried out
at the Royal Veterinary and Agricultural
University, Copenhagen, Denmark. Briefly,
the sections were de-paraffinated by heat-
ing up to 70 °C for 10–15 min and baths of
xylene and ethanol. After a pre-treatment
with 0.018% protease for 5 min at room
temperature, the sections were blocked
with 5% normal pig serum and incubated
overnight at 4 °C with a polyclonal bovine-
serum against BRSV in a 1:600 dilution
(primary antibody). After this, the sections
were incubated with 0.9% streptavidin
(DAKO, Glostrup, Denmark) and follow-
ing with 0.9% biotinylated alkaline phos-
phatase for 30 min at 37 °C (DAKO). Fast
red (KemEnTec, Copenhagen, Denmark)
was used for 10–15 min to visualize the
positive reactions. The sections were coun-
ter-stained with Harris haematoxylin and
mounted in Glycergel (DAKO) for light
microscopy.
2.7. RNA extraction 
The RNA extraction from approxi-
mately 100 mg of tissue samples was
carried out using phenol guanidine isothio-
cyanate (TRIzol, InvitrogenTM, Carlsbad,
California, USA) and chloroform. The pre-
cipitation of the total RNA was performed
with 100% ethanol followed by centrifu-
gation. The pellet was washed with 70%
ethanol and diluted in 25 µL of water
containing 0.1% of diethyl pyrocarbonate
(DEPC, Sigma-Aldrish Co., Missouri, USA).
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Positive controls have been processed
using the virus multiplied in CER cell cul-
tures. The RNA extracted from non-
infected mice tissue was used as the nega-
tive control. 
2.8. RT-nested-PCR 
The technique was standardized to amplify
a fragment of 481 bp corresponding to a part
of the F gene and 371 bp corresponding to
a part of the G gene of the BRSV, using
outer and inner primers described by Vilcek
et al. [28].
The different RT-nested-PCR steps, from
RNA extraction until the second amplifica-
tion round, have been processed in different
rooms to avoid contamination problems.
2.8.1. cDNA synthesis  
For the synthesis of the cDNA, the com-
mercial kit, SuperScriptTM II Rnase H
Reverse Transcriptase (InvitrogenTM, Cal-
ifornia, USA) was used according to the
manufacturers’ recommendations and prim-
ers B2A (F gene) or B6A (G gene) designed
by Vilcek et al. [28]. 
2.8.2. PCR reactions 
For a final volume of 50 µL, the follow-
ing reagents were added in a PCR tube:
5 µL 10× amplification buffer [200 mM
Tris-HCl (pH 8.4), 500 mM KCl]; 2 µL
dNTP 10 mM; 1 µL primer B1 (F gene;
10 pmoles) or B5A (G gene; 10 pmoles);
1 µL primer B2A (F) or B6A (G); 0.6 µL of
the enzyme PlatinumTM Pfx DNA Poly-
merase 2.5 U/µL (InvitrogenTM, Califor-
nia, USA); 1 µL of MgSO4 (50 mM); 2 µL
cDNA and sterilized distilled water with
DEPC until reaching the final volume. The
mixture was heated for 2 min at 94 °C for
the initial denaturation. The amplification
was carried out in a thermal cycler PCR
System 9700 (Gene Amp, Applied Biosys-
tems, Perkin-Elmer, California, USA). The
cycling program consisted of denaturation
at 94 °C for 30 s, annealing at 55 °C for 30 s
and elongation at 72 °C for 1 min. Twenty-
five cycles of amplification were carried
out. The second PCR was done using 2 µL
of the first PCR product, substituting the
primers for B3 and B4A (F gene) or B7A
and B8 (G gene). After initial denaturation
at 94 °C for 2 min, the thermal cycle con-
sisted of denaturation at 94 °C for 30 s,
annealing at 62 °C for 45 s and elongation
at 72 °C for 1 min. Thirty-five cycles of
amplification were carried out. The last
cycle of elongation was prolonged for
7 min in both PCR reactions. 
RT-nested-PCR reactions were submit-
ted to electrophoresis in 0.7% agarose gel
containing 0.5 mg of ethidium bromide/
mL, run at 110 V for 60 min. The molecular
sizes of the products were compared with
those of a 50 bp ladder (InvitrogenTM,
California, USA). The ethidium bromide-
stained bands were visualized by UV light
and recorded with the equipment Image
Master VDS (Amersham Biosciences, Buck-
inghamshire, England). 
2.9. RT-nested-PCR sensitivity analysis
The cDNA synthesized from viral RNA
extracted from infected CER cells, both for
the F gene and G gene, was quantified
by spectrophotometry, submitted to serial
dilutions (10–1 to 10–3) and amplified by
RT-nested-PCR. 
3. RESULTS
3.1. Animal infections  
The balb/c infected mice did not present
apparent clinical signs during this experi-
ment. However, macroscopic lesions were
observed in the pulmonary tissue of one of
the infected and sacrificed animals with
10 dpi, characterized for intense hemor-
rhage. Histopathological analysis demon-
strated infiltration of mononuclear cells in
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the lungs with intense thickening of alveo-
lar walls and mucosal oedema, periarterial
oedema, mononuclear infiltrate in lamina
propria, multifocal proliferative tracheitis
and hyperplasia of the mucus glands in the
tracheae (data not shown).
3.2. Immunohistochemistry
A positive result was detected only in
three lung samples extracted from mice
five days post-infection. The positive reac-
tion was present in bronchial epithelial cells
(Fig. 1).
3.3. RT-nested-PCR 
Positive results were obtained with the
amplifications of the fragment correspond-
ing to a part of the G gene, from RNA
extracted from 2 lungs and 2 tracheae col-
lected on 3 dpi; 2 lungs and 1 trachea col-
lected on 5 dpi; 1 lung and 1 trachea
collected on 7 dpi and 2 lungs and 2 tracheae
collected on 10 dpi. In the RT-nested-PCR
corresponding to the F gene, however, it
was not possible to observe any amplified
fragment (Tab. I and Fig. 2). 
3.4. Nested-PCR sensitivity analysis
The technique amplified the fragment
corresponding to the G gene of the material
diluted up to 10-2 (containing 1225 µg/mL
of cDNA), while the fragment correspond-
ing to the F protein could only be amplified
from pure material (1 197.5 µg/mL; Fig. 3).
4. DISCUSSION
Several small experimental animals
have been used as models of infections with
RSV. In this study, balb/c mice were elected
to be infected with the BRSV-25-BR strain
due to the impossibility of maintaining
large experimental animals – such as calves
– in our institution. Several authors have
used this lineage mice during experiments
carried out with HRSV [4, 11, 17, 24, 25]
Figure 1. A, B and C: Immunohistochemistry of 3 infected mice lungs sacrificed 5 days post-
infection. The red coloration represents the infected cells (see www.edpsciences.org/vetres for a
colour version of this figure). D: negative control (magnified 20×). 
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and BRSV [4]. According to Kumar et al.
[17], balb/c mice provide a good model
for the study of infection by HRSV, in
which the infection duration and the pulmo-
nary pathology resembles those in human
beings. Viral replication was detected in
balb/c mice experimentally infected with
RSVs through tests of immunofluorescence
[24], in situ hybridization [11] and ELISA
[4, 17]. Bastien et al. [3, 4] obtained virus
titles in balb/c mice challenged with HRSV
and BRSV during experiments with syn-
thetic peptides to confer protection against
these viruses. Notwithstanding, some authors
mentioned the great difficulty to get BRSV
detection after the infection of mice. They
comment that some reasons for this phe-
nomenon may exist, since many strains do
not grow well in mice and this would seri-
ously reduce the possibility of viral nucleic
acid detection. However, intranasal inocu-
lation of balb/c mice with live BRSV
induces similar levels of serum antibodies
as those detected in mice infected with
HRSV (G. Taylor, Institute for Animal
Health, Compton, UK, personal communi-
cation) and BRSV could undergo an
abortive infection in the lungs of mice
(A. Easton, University of Warwick, Coven-
try, UK, personal communication). Taylor
et al. [24] have also concluded that the
growth of the HRSV strain in different cell
lines affects its infectivity for mice.
In the present study, no clinical signs
were observed in the animals, in agreement
with the findings of some authors [4, 11, 17,
24]. However, it was possible to detect
BRSV in mice tissue by RT-nested-PCR
and immunohistochemistry which, to the
author’s knowledge, was the first time that
this virus was detected in balb/c mice. The
F gene was chosen as the target for the RT-
nested-PCR because it is one of the most
conservative RSV genes and, consequently,
represents a good alternative to be used for
virus detection in calves with unknown his-
tory about this virus. The G gene, however,
is described as the more variable portion of
the RSV genome, and can be used in the
future in Brazilian field sample character-
ization. Therefore, these genes are good
choices to study the BRSV in our country.
The RT-nested-PCR was able to amplify a
fragment corresponding to a part of the
G gene from the RNA extracted from the
lungs and tracheae collected 3, 5, 7 and
10 dpi but only from one or two infected
mice each day. However, in the amplifica-
tions corresponding to the F gene, it was not
possible to observe any amplified fragment.
The RT-nested-PCR sensitivity, up to one
hundred times superior in the amplification
of the G gene fragment as compared to the
F gene fragment, may explain the amplifi-
cation of only the first one of the infected
mice tissues. Probably, the viral RNA
extracted from this material was enough
only to allow the amplification of the G gene
and not the F gene. Although there are no
reports of similar results in the literature,
this phenomenon may have occurred due to
inherent conditions of the primers. Even so,
Table I. The results of RT-nested-PCR of BRSV F and G genes from the tracheae and lungs of
experimentally infected balb/c mice.
Days post-inoculation 
(dpi)
No. F gene amplified/
total animals
No. G gene amplified/
total animals Positive total
Trachea Lung Trachea Lung
3 days 0/12 0/12 2/12 2/12 4
5 days 0/12 0/12 1/12 2/12 3
7 days 0/12 0/12 1/12 1/12 2
10 days 0/12 0/12 2/12 2/12 4
Positive total 0 0 6 7 13
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more studies to analyze this must be per-
formed. Furthermore, only lungs five days
post-infection were positive by immuno-
histochemistry. This can be explained by
the higher sensitivity normally shown in
PCR reactions when compared to immuno-
histochemistry, as observed by other authors
in the detection of several infectious agents,
including viruses [6, 13, 14, 26]. By immu-
nohistochemistry the presence of the BRSV
antigen in bronchial epithelial cells, as
detected by Prince et al. [22] in cotton rats
infected with HRSV, was verified. Differ-
ently, Taylor et al. [25] found positive
immunohistochemistry reactions in the small
scattered foci in cells of alveolar walls using
a reference strain of HRSV for inoculation
in balb/c mice. In this study, nevertheless,
we also had considerable difficulty in recov-
ering BRSV from balb/c tissues, and it was
necessary to use a great number of animals
to obtain the results shown here.  
Figure 2. RT-nested-PCR for the detection of a part of the G genes. M: Molecular weight marker.
1: positive control of the F gene (fragment of 481 bp). 2: positive control of the G gene (fragment
of 371 pb). 3, 5, 7, 9: F gene from the lungs of infected mice on 3, 5, 7 and 10 dpi, respectively. 4,
6, 8, 10: G gene from the lungs of infected mice on 3, 5, 7 and 10 dpi, respectively. 11: F gene from
the tracheae of infected mice on 10 dpi. 12, 18: G gene from the tracheae of infected mice on 10 dpi.
15, 16, 17: G gene from the tracheae of infected mice on 3, 5, and 7 dpi. 13, 14: negative controls. 
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Although the present study permitted
the detection of BRSV in experimentally
infected balb/c mice, this procedure showed
difficulties. The results here obtained dem-
onstrate that the use of balb/c mice without
any artifice can be laborious and often
unsuccessful. The use of immunodepressed
mice could probably represent a good alter-
native in order to obtain better results with
experimental models to BRSV. Moreover,
in our study, only one cell line type and
virus strain were tested. It is important to
emphasize that studies using more cell lines
and other virus strains to complement our
unedited data, should be carried to analyze
the real application condition of this partic-
ular experimental animal. 
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